The Chop Finally Turned into a New Record High
Recap - The range that had dominated trading in the S&P 500 for all of 2015 (which we wrote about last weekend) finally came to an end this Friday (the … Continue Reading
Read nowSearch Results for gene therapy
“Chop” is Still the Name of the Game in the Markets
These Biotech IPO’s Just. Don’t. Stop.
The Highest Biotech Fliers Last Week were the Hardest Hit this Week
What Does it Mean When EVERYONE’s Optimistic About Biotech Stocks?
The Biggest Investor Event in Healthcare Starts Next Week
Recap - Investors descend en masse on San Francisco next week for the annual JP Morgan healthcare conference, a major event for the sector that historically generates … Continue Reading
Read now
Here’s What bluebird bio Investors Should Know about Sickle Cell Disease
Research - By Zack Fink and guest contributor Dan Marks Bluebird bio (BLUE) will release data from the first Sickle Cell Disease patient treated with its LentiGlobin gene therapy … Continue Reading
Read now